Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, mult (Q44699072)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 July 2013
edit
Language Label Description Also known as
English
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, mult
scientific article published on 29 July 2013

    Statements

    Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, mult (English)
    Stephen Rd Johnston
    Lucy S Kilburn
    Paul Ellis
    David Dodwell
    David Cameron
    Larry Hayward
    Young-Hyuck Im
    Jeremy P Braybrooke
    A Murray Brunt
    Kwok-Leung Cheung
    Rema Jyothirmayi
    Anne Robinson
    Duncan Wheatley
    Gill Coombes
    Nicole Sergenson
    Hui-Jung Sin
    Elizabeth Folkerd
    SoFEA investigators
    29 July 2013
    989-998

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit